Such studies have the potential to provide added‐value in future risk‐stratification for men newly diagnosed with intermediate‐ or high‐risk localized or locally advanced PCa undergoing radical RT, based on a personalized medicine genomic analysis of baseline molecular features of each malignancy, alongside conventional risk parameters such as PSA, tumor grade and stage.3, 18, 19, 20. Here, KLK3 is linked to neoplasm.